Citations

Mayo Clinic

Showing 10 of 108599 citations.

Evaluation of Testing of Acute Leukemia Samples: Survey Result From the College of American Pathologists
George, Tracy I. , Tworek, Joseph A., Thomas, Nicole , Fatheree, Lisa A., Souers, Rhona J., Nakhleh, Raouf E. , Arber, Daniel A. , George, Tracy I

Archives of Pathology & Laboratory Medicine | May 24, 2017 | Volume: 141 | Issue: 8 | Pages: 1101-1106

10.5858/arpa.2016-0398-cp | PMID 28537804 Get It

Context.— The classification and prognosis determination in acute leukemia (AL) are complex and it is unclear what testing is being performed in practice. Objective.— To survey physicians describing their current practice of test ordering in the diagnosis of AL. Design.— In anticipation of a guideline by the College of American Pathologists (CAP) and the American Society for Hematology on laboratory testing needed for the initial workup of AL, a baseline survey was designed by an expert panel from CAP. Members of professional societies were asked to describe their current practice of test ordering. Results.— Two hundred ninety-four responses were received with 258 respondents analyzed after the first qualifying survey question regarding initial diagnosis of AL. One hundred seventy-six of 249 respondents (70.7%) were board-certified hematopathologists. Flow cytometry and karyotype analysis were routinely performed for acute myeloid leukemia (AML) (99.1% [232 of 234] and 96.2% [225 of 234], respectively) and acute lymphoblastic leukemia (ALL) (98.3% [229 of 233] and 96.6% [225 of 233], respectively). In addition, fluorescence in situ hybridization studies were routinely performed by 81.2% (190 of 234) of respondents for AML and 85.0% (198 of 233) of respondents for ALL; other molecular studies were performed by 78.2% (183) for AML and 54.9% (128) for ALL; immunohistochemistry by 44.9% (105) for AML and 47.6% (111) for ALL; and cytochemistry by 24.8% (58) for AML and 14.2% (33) for ALL. Conclusions.— While flow cytometry and karyotyping are routinely reported as being performed for the diagnosis of AL, there is marked variation in the reporting of testing patterns for other genetic studies, immunohistochemistry, and cytochemistry.
A Versatile Protocol for Studying Calvarial Bone Defect Healing in a Mouse Model
Samsonraj, Rebekah M. , Dudakovic, Amel , Zan, Pengfei, Pichurin, Oksana , Cool, Simon M. , Wijnen, André J. van , van Wijnen, Andre J, van Wijnen, Andre J

Tissue Engineering Part C: Methods | May 24, 2017 | Volume: 23 | Issue: 11 | Pages: 686-693

10.1089/ten.tec.2017.0205 | PMID 28537529 Get It

Aneurysm Morphology and Prediction of Rupture: An International Study of Unruptured Intracranial Aneurysms Analysis
Brown, Robert D., Torner, James C., Fargen, Kyle M , Raghavan, Madhavan L. , Piepgras, David G., Meissner, Irene, Investigators, on behalf of the International Study of Unruptured Intracranial Aneurysms, Torner, James C. , Mocco, J , Capuano, Ana Werneck , Huston, John , Investigators, on behalf of the International Study of Unruptured Intracranial Aneurysms, Fargen, Kyle M

Neurosurgery | May 24, 2017 | Volume: 82 | Issue: 4 | Pages: 491-496

10.1093/neuros/nyx226 | PMID 28605486 Get It

Abstract BACKGROUND There are conflicting data between natural history studies suggesting a very low risk of rupture for small, unruptured intracranial aneurysms and retrospective studies that have identified a much higher frequency of small, ruptured aneurysms than expected. OBJECTIVE To use the prospective International Study of Unruptured Intracranial Aneurysms cohort to identify morphological characteristics predictive of unruptured intracranial aneurysm rupture. METHODS A case-control design was used to analyze morphological characteristics associated with aneurysm rupture in the International Study of Unruptured Intracranial Aneurysms database. Fifty-seven patients with ruptured aneurysms during follow-up were matched (by size and location) with 198 patients with unruptured intracranial aneurysms without rupture during follow-up. Twelve morphological metrics were measured from cerebral angiograms in a blinded fashion. RESULTS Perpendicular height ( P = .008) and size ratio (ratio of maximum diameter to the parent vessel diameter; P = .01) were predictors of aneurysm rupture on univariate analysis. Aspect ratio, daughter sacs, multiple lobes, aneurysm angle, neck diameter, parent vessel diameter, and calculated aneurysm volume were not statistically significant predictors of rupture. On multivariate analysis, perpendicular height was the only significant predictor of rupture (Chi-square 7.1, P -value .008). CONCLUSION This study underscores the importance of other morphological factors, such as perpendicular height and size ratio, that may influence unruptured intracranial aneurysm rupture risk in addition to greatest diameter and anterior vs posterior location.
Tumor Progression Following Petroclival Meningioma Subtotal Resection: A Volumetric Study
Hunter, Jacob B. , O’Connell, Brendan P., Carlson, Matthew L. , Chambless, Lola, Yawn, Robert J. , Mistry, Akshitkumar M. , Thompson, Reid C., Weaver, Kyle D., Wanna, George B. , Wang, Ray , Hunter, Jacob B

Operative Neurosurgery | May 24, 2017 | Volume: 14 | Issue: 3 | Pages: 215-223

10.1093/ons/opx098 | PMID 28541487 Get It

Abstract BACKGROUND One study has investigated postoperative growth rates following subtotal resection of petroclival meningiomas utilizing linear measurements, which are insensitive to the multidimensional complex growth of meningiomas, to estimate tumor volume. OBJECTIVE To describe petroclival meningioma growth patterns following less-than-complete resection utilizing volumetric analysis and to identify variables associated with tumor progression. METHODS Patients with surgically resected WHO grade I petroclival meningiomas were retrospectively reviewed (1999-2015). Image analysis software was utilized to perform volumetric analyses of tumor size and growth on serial MRI studies. The impact of preoperative and postoperative variables on tumor growth after subtotal resection was analyzed. An increase in tumor volume of at least 20% was defined as “tumor growth.” RESULTS Twenty-three patients had immediate preoperative and serial postoperative MRI studies available for review. The mean preoperative tumor volume was 20.9 cm 3 (range 0.4-54.6). The mean extent of resection was 75.5% (range 31.5%-100.0%). At a mean follow-up of 24.8 mo, 12 tumors (66.7%) exhibited radiological tumor growth, while 6 tumors did not change in size. The median annual volumetric growth rate was 2.82 cm 3 /yr (range –0.34 to 10.1). Extent of resection and immediate postoperative tumor volume were significantly correlated with the annual volumetric growth rate following resection. At last follow-up, 3 (13%) patients required further intervention. CONCLUSION The majority of petroclival meningiomas exhibit growth following subtotal resection. Extent of resection is strongly associated with risk for disease progression following surgery.
Discordance Between Physician Assessment and Patient-Reported Depressive Symptoms in Parkinson Disease
Lachner, Christian , Armstrong, Melissa J. , Gruber‐Baldini, Ann L. , Rezvani, Zahra , Reich, Stephen G. , Fishman, Paul S., Salazar, Richard, Shulman, Lisa , Armstrong, Melissa J

Journal of Geriatric Psychiatry and Neurology | May 24, 2017 | Volume: 30 | Issue: 4 | Pages: 191-195

10.1177/0891988717710335 | PMID 28535723 Get It

Objective: To assess concordance between physician assessment and patient-reported symptoms when screening for depression in Parkinson disease (dPD). Background: Depression in Parkinson disease is highly prevalent (∼40%) and has a significant impact on quality of life and disability, yet physician recognition and treatment remain inadequate. Methods: One thousand seventy-six patients with PD completed the Brief Symptom Inventory-18 (BSI-18), a screening questionnaire for psychiatric symptoms, which was compared to item #3 (depression) on the Unified Parkinson’s Disease Rating Scale (UPDRS). Results: The mean BSI-18 depression score was 51.4 (9.7). Of the 170 (16%) patients screening positive for dPD on the BSI-18, 104 (61%) were not recognized as depressed by neurologists on the UPDRS. Factors associated with lower neurologist recognition included male gender, better mental health quality of life, and lack of antidepressant use. Conclusion: More than 60% of patients screening positive for depression on self-report were not recognized by neurologists on the UPDRS. A patient-reported screening tool for depression may improve recognition and management of dPD.
Cost of Alteplase Has More Than Doubled Over the Past Decade
Kleindorfer, Dawn , Demaerschalk, Bart, Saver, Jeffrey, Broderick, Joseph P. , Demaerschalk, Bart M. , Saver, Jeffrey L.

Stroke | May 24, 2017 | Volume: 48 | Issue: 7 | Pages: 2000-2002

10.1161/strokeaha.116.015822 | PMID 28536176 Get It

Background and Purpose— Intravenous alteplase (tissue-type plasminogen activator) has been shown to be cost-effective because of savings in long-term disability. In October of 2005, an increased DRG payment to hospitals for alteplase-treated stroke patients was introduced. We sought to describe the trends in the cost of alteplase over time, in comparison to trends in hospital reimbursement in the United States. Methods— Using publicly available information on the Centers for Medicare and Medicaid Services (CMS) website ( www.cms.gov ), we obtained CMS quarterly payment amounts between January 1, 2005, and October 1, 2014, for alteplase, listed as alteplase recombinant, per mg. CMS payment amounts are the manufacturer’s average sales price+6% until April 2014, when it was lowered to +4.3%. Estimates for DRG base payments were calculated within the Medicare Provider and Analysis Review (MEDPAR) for fiscal years 2006 (DRG 559) and 2013 (MS DRGs 61, 62, and 63) as (DRG relative weights)×(standardized operating and capital amount). The consumer price index was also queried for all prescription drugs, urban areas, during the same study period as reference. Results— The CMS payment amount for alteplase per milligram was $30.50 in January 2005 and $64.30 in October 2014. Trends in the CMS payment amounts for alteplase increased by 111% between 2005 and 2014. The consumer price index for all prescription drugs increased by 30.2% in the same time frame. The base payment for alteplase-treated stroke admissions was $11 173 in 2006 and $12 064 in 2013, an 8% increase. Conclusions— We found a striking increase in the cost of alteplase over the last decade, with a 100 mg vial now with a CMS payment of ≈$6400, a >100% increase over 10 years. During the same time frame, the DRG base payment to hospitals increased by only 8%, and alteplase cost increased from 27% of the payment in 2006 to 53% in 2013. Researchers and stroke physicians should be aware of these changes in drug costs and their impact on cost-effectiveness analyses.
The Birkett Lecture: Avoiding the unhappy patient: The ABCs of rapport building
Kern, Eugene B. , Kern, Eugene Barton

The Laryngoscope | May 24, 2017 | Volume: 127 | Issue: 11 | Pages: 2517-2521

10.1002/lary.26657 | PMID 28543001 Get It

The clinical significance of esophagogastric junction outflow obstruction and hypercontractile esophagus in high resolution esophageal manometry
Schupack, Daniel , Katzka, David A. , Geno, Debra M., Schupack, D , Ravi, Karthik

Neurogastroenterology & Motility | May 24, 2017 | Volume: 29 | Issue: 10 | Pages: 1-9

10.1111/nmo.13105 | PMID 28544670 Get It

AbstractBackgroundAlthough major manometric abnormalities, the significance of esophagogastric junction outflow obstruction (EGJOO) and hypercontractile esophagus (HE) is poorly understood. We sought to determine long term outcomes for EGJOO and HE.MethodsHigh‐resolution impedance manometry (HRIM) studies conducted from 5/30/2012 to 8/1/2014 consistent with EGJOO and HE and normal studies from 5/30/12 to 11/1/12 were identified. Standardized follow up was conducted with a phone survey utilizing the impact dysphagia questionnaire (IDQ‐10).Key Results56 EGJOO, 40 HE patients and 33 controls were identified. Structural evaluation with EGD and esophagram did not differ among groups. Use of opiates in EGJOO (P<.05) and of anticholinergics in EGJOO and HE patients was more prevalent than in controls (P<.005). Dysphagia was more common in EGJOO (P<.05) and chest pain more common in HE (P<.005) at presentation. While HE patients were more likely to be symptomatic (P<.05), the majority of EGJOO and HE patients overall were asymptomatic at a mean 2.8 years follow up without medical or procedural intervention in the majority (72.5%). Symptom persistence at follow up was predicted by maximum distal contractile integral (DCI) and IRP in both EGJOO and HE (P<.05).Conclusions & InferencesThe majority of patients with EGJOO and HE appear to have a benign clinical course similar to controls in the absence of specific treatment. However, the combination of abnormal IRP and DCI in both HE and EGJOO appears to discriminate an important subset of patients who may benefit from treatment. Further refinement of manometric criteria may therefore provide more useful clinical definitions of EGJOO and HE.
Eyes-Closed Single-Limb Balance is Not Related to Hypermobility Status in Dancers
Marnili, Tiffany A., Harmon-Matthews, LindsayE., Davis-Coen, J. Hope, Hewett, Timothy E. , Marnili, Tiffany A., Harmon-Matthews, Lindsay Elizabeth , Willigenburg, Nienke Willemien

Journal of Dance Medicine & Science | May 23, 2017 | Volume: 21 | Issue: 2 | Pages: 70-75

10.12678/1089-313x.21.2.70 | PMID 28535850 Get It

Hypermobility may be associated with decreased lower extremity proprioception, which in turn may increase injury risk. The prevalence of hypermobility in dancers varies across studies, but joint hypermobility appears to be more common in dancers than in the general population. The purpose of this study was to determine how hypermobility affects eyes-closed single-limb balance as an indirect measure of proprioception in dancers. The secondary aim was to compare hypermobility and balance across dancer affiliation groups. Data were collected from 45 professional dancers, 11 collegiate modern dancers, 227 student dancers, and 15 pre-professional dancers during routine dance screens. Dancer hypermobility status was assessed via an eight-point Beighton-Horan Laxity test. Single-limb balance time, in seconds, was assessed in parallel position with the eyes closed. Hypermobile (HM) and non-hy-permobile (NHM) dancers showed very similar balance times (HM median: 36.5 seconds; NHM median: 33.0 seconds; p = 0.982). Hypermobility was not significantly different between dancer affiliation groups (p = 0.154): 47% in ballet academy students, 27% in collegiate modern dancers, 62% in pre-professional dancers, and 36% in professional dancers. The student, pre-professional, and professional ballet dancers all demonstrated longer balance times than the collegiate modern dancers; however, this difference was only significant between the professional ballet dancers and collegiate modern dancers (p = 0.026). Dancers demonstrated a higher prevalence of hypermobility than what has been reported for the general population. Joint hypermobility did not affect eyes-closed single-limb balance time. Future studies are needed to determine if joint hypermobility affects more sensitive measures of proprioception and risk of injury.
Reply
Sekiguchi, Hiroshi , Sekiguchi, Hiroshi , Orde, Sam R.

Journal of Ultrasound in Medicine | May 23, 2017 | Volume: 36 | Issue: 6 | Pages: 1285-1286

10.1002/jum.14205 | PMID 28543727 Get It